Plasma homocysteine concentrations in a Belgian school-age population

American Journal of Clinical Nutrition

Volumn 69, Issue 5, 1999, Pages 968-972

  De Laet, Corinne ^a   Wautrecht, Jean Claude ^b   Brasseur, Daniel ^b   Dramaix, Michèle ^b   Boeynaems, Jean Marie ^b   Decuyper, Jean ^b   Kahn, André ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NONE

Author keywords

Belgium; Cardiovascular diseases; Children; Folate; Homocysteine; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; ADULTHOOD; AMINO ACID BLOOD LEVEL; ARTICLE; BELGIUM; CARDIOVASCULAR DISEASE; CHILD; CHILD NUTRITION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; NORMAL HUMAN; SEX DIFFERENCE; BLOOD; PRESCHOOL CHILD; PUBERTY;

ADOLESCENT; BELGIUM; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; PUBERTY; VITAMIN B 12;

EID: 0032587458     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.5.968     Document Type: Article

References (25)

1. Mudd SH, Levy HL. Disorders of transulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited diseases. New York: McGraw Hill, 1995:1279-327.
2. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
4. The European Concerted Action Project. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277:1775-81.
5. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
6. Nygård O, Vollset SE, Refsum H, et al. Total homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
7. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
8. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
9. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
10. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
11. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
12. Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am J Epidemiol 1996;143:845-59.
13. Guttormsen AB, Ueland PM, Nesthus I, et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia. J Clin Invest 1996;98:2174-83.
14. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
15. Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res 1996;40:47-52.
16. Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem 1997;43:690-2.
17. Reddy MN. Reference ranges for total homocysteine in children. Clin Chim Acta 1997;262:153-5.
18. Jacques PF, Sulsky SI, Sadowski JA, Phillips JC, Rush D, Willett WC. Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr 1993;57:182-9.
19. McNulty H, Eaton-Evans J, Cran G, et al. Nutrient intakes and impact of fortified breakfast cereals in schoolchildren. Arch Dis Child 1996;75:474-81.
20. Brattström L, Lindgren A, Israelsson B, Andersson A, Hutelberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633-41.
21. Wouters MG, Moorrees MTH, Van der Mooren MJ, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-5.
22. Andersson A, Hultberg B, Brattström L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992;30:377-9.
23. Lien EA, Anker G, Lonning PE, Refsum H, Ueland PM. Effects of hormones on the plasma levels of the atherogenic amino acid homo-cysteine. Biochem Soc Trans 1997;25:33-5.
24. Kim MH, Kim E, Passen EL, Meyer J, Kang S. Cortisol and estradiol: non genetic factors for hyperhomocysteinemia. Metabolism 1997;46:247-9.
25. Genest JJ, McNamara JR, Upson B, et al. Prevalence of familial hyperhomocysteinemia in men with premature coronary artery disease. Arterioscler Thromb 1991;11:1129-36.